Table 1.
Participant characteristics.
| Characteristics | Total (N=38) | Control (N=22) | Intervention N=16 | |||
| Age (years), mean (SD) | 62.9 (7) | 64.8 (6) | 60.3 (7) | |||
| Sex, n (%) | ||||||
|
|
Female | 19 (50) | 11 (50) | 8 (50) | ||
|
|
Male | 19 (50) | 11 (50) | 8 (50) | ||
| Race, n (%) | ||||||
|
|
White | 35 (92) | 22 (100) | 13 (81) | ||
|
|
Black | 3 (7) | 0 (0) | 3 (18) | ||
|
|
Other | 0 (0) | 0 (0) | 0 (0) | ||
| Ethnicity, n (%) | ||||||
|
|
Hispanic | 1 (2) | 1 (4) | 0 (0) | ||
| Partnered, n (%) | 33 (87) | 19 (86) | 14 (87) | |||
| College graduate, n (%) | 30 (79) | 18 (81) | 12 (75) | |||
| Employment, n (%) | ||||||
|
|
Employed | 18 (47) | 6 (27) | 12 (75) | ||
|
|
Retired | 16 (42) | 12 (54) | 4 (25) | ||
|
|
Disabled | 1 (2) | 1 (4) | 0 (0) | ||
|
|
Homemaker | 1 (2) | 1 (4) | 0 (0) | ||
| Income (US $), n (%) | ||||||
|
|
<30,000 | 3 (8) | 3 (13) | 0 (0) | ||
|
|
30,000-59,999 | 5 (13) | 3 (13) | 2 (13) | ||
|
|
60,000-89,999 | 9 (23) | 4 (18) | 5 (31) | ||
|
|
>90,000 | 21 (55) | 12 (55) | 9 (56) | ||
| Multiple myeloma, n (%) | 14 (37) | 8 (36) | 6 (38) | |||
| Chronic lymphocytic leukemia, n (%) | 24 (63) | 14 (64) | 10 (63) | |||
| Remission, n (%) | 16 (42) | 11 (50) | 5 (31) | |||
| Current treatment, n (%) | 17 (45) | 10 (45) | 7 (44) | |||
| Past treatment, n (%) | ||||||
|
|
None | 13 (34) | 6 (27) | 7 (44) | ||
|
|
Surgery | 2 (5) | 2 (9) | 0 (0) | ||
|
|
Radiation therapy | 2 (5) | 1 (5) | 1 (6) | ||
|
|
Intravenous therapy | 19 (50) | 13 (59) | 6 (38) | ||
|
|
Oral therapy | 18 (47) | 11 (50) | 7 (44) | ||
|
|
Stem cell transplant | 9 (23) | 6 (27) | 3 (19) | ||
| Other cancer, n (%) | 12 (32) | 7 (32) | 5 (31) | |||